Home › Forums › Science! › New article separates GLP-1 marketing myths from research realities

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #2016
    Ragen Chastain

      Hello AWSIM!

      The article GLP-1s for Weight Loss – A Triumph of Marketing over Patient Care by Angela Meadows, Louise Adams and me was just published!

      The paper separates marketing hype from what the research actually finds to help you parse and respond to claims about GLP-1s  for weight loss and cardiovascular health. We also created  supplemental tables that offer clear views of the phase 3 weight loss trials of semaglutide and tirzepatide, so that you can clearly see information like adverse events data and how many people in the trials failed to reach the weight loss endpoints, which we hope will be helpful for both refuting overblown claims and possible informed consent conversations.

      The article is open access an you can find it here:

      https://www.tandfonline.com/doi/full/10.1080/21604851.2026.2646492

      #2017
      Ashleigh Shields

        Hi Ragen! Are you cool with me weaving this into our newsletter? Would you also like to email me any specific highlights you think people in AWSIM would like to know from this? If so, my email is a.shields@northeastern.edu!

        Thank you for all of the important work you do!

        #2020
        Ragen Chastain

          Hi Ashleigh,

          We are very cool with you weaving it into the newsletter , I’ll send you an email about specific highlights!

        Viewing 3 posts - 1 through 3 (of 3 total)
        • You must be logged in to reply to this topic.